A novel yeast cell-based screen identifies flavone as a tankyrase inhibitor.

[1]  Marc W. Kirschner,et al.  Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling , 2009, Nature.

[2]  A. Ashworth,et al.  Targeting Tankyrase 1 as a therapeutic strategy for BRCA-associated cancer , 2009, Oncogene.

[3]  Hiroko Yamada,et al.  Human protein factory for converting the transcriptome into an in vitro–expressed proteome , 2008, Nature Methods.

[4]  S. Horinouchi,et al.  Global Analysis of Gel Mobility of Proteins and Its Use in Target Identification* , 2008, Journal of Biological Chemistry.

[5]  H. Taoka,et al.  Inhibition of splicing and nuclear retention of pre-mRNA by spliceostatin A in fission yeast. , 2007, Biochemical and biophysical research communications.

[6]  E. Wouters,et al.  Flavone as PARP-1 inhibitor: its effect on lipopolysaccharide induced gene-expression. , 2007, European journal of pharmacology.

[7]  T. Tsuruo,et al.  Evaluation of tankyrase inhibition in whole cells. , 2007, Methods in molecular biology.

[8]  Y. Hiraoka,et al.  ORFeome cloning and global analysis of protein localization in the fission yeast Schizosaccharomyces pombe , 2006, Nature Biotechnology.

[9]  C. Harley,et al.  Lipid modification of GRN163, an N3′ → P5′ thio-phosphoramidate oligonucleotide, enhances the potency of telomerase inhibition , 2005, Oncogene.

[10]  Thomas Helleday,et al.  Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase , 2005, Nature.

[11]  Alan Ashworth,et al.  Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy , 2005, Nature.

[12]  S. Horinouchi,et al.  pDUAL, a multipurpose, multicopy vector capable of chromosomal integration in fission yeast , 2004, Yeast.

[13]  G. de Murcia,et al.  The PARP superfamily , 2004, BioEssays : news and reviews in molecular, cellular and developmental biology.

[14]  T. Tsuruo,et al.  Functional Subdomain in the Ankyrin Domain of Tankyrase 1 Required for Poly(ADP-Ribosyl)ation of TRF1 and Telomere Elongation , 2004, Molecular and Cellular Biology.

[15]  Susan Smith,et al.  TRF1 is degraded by ubiquitin-mediated proteolysis after release from telomeres. , 2003, Genes & development.

[16]  T. Tsuruo,et al.  Telomere shortening and growth inhibition of human cancer cells by novel synthetic telomerase inhibitors MST-312, MST-295, and MST-1991. , 2002, Molecular cancer therapeutics.

[17]  K Jarnagin,et al.  Novel inhibitors of poly(ADP-ribose) polymerase/PARP1 and PARP2 identified using a cell-based screen in yeast. , 2001, Cancer research.

[18]  T. Lange,et al.  Tankyrase, a poly(ADP-ribose) polymerase at human telomeres. , 1998, Science.

[19]  J. Shay,et al.  A survey of telomerase activity in human cancer. , 1997, European journal of cancer.

[20]  Bas van Steensel,et al.  Control of telomere length by the human telomeric protein TRF1 , 1997, Nature.

[21]  B. van Steensel,et al.  Control of telomere length by the human telomeric protein TRF1 , 1997, Nature.

[22]  M. Yamasaki,et al.  bfr1+, a novel gene of Schizosaccharomyces pombe which confers brefeldin A resistance, is structurally related to the ATP-binding cassette superfamily , 1995, Journal of bacteriology.

[23]  C B Harley,et al.  Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.

[24]  M. Nishiyama,et al.  A leptomycin B resistance gene of Schizosaccharomyces pombe encodes a protein similar to the mammalian P‐glycoproteins , 1992, Molecular microbiology.

[25]  S. Moreno,et al.  Molecular genetic analysis of fission yeast Schizosaccharomyces pombe. , 1991, Methods in enzymology.